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Case Synopsis
An 8-year-old boy with diagnosis of X-linked 
GCD, chronically medicated with trimethoprim/ 
sulfamethoxazole and itraconazole, was referred 
to the dermatology department for a sudden 
pruritic rash in sun-exposed areas. The mother also 
mentioned a chronic dermatosis of palms and soles, 
respectively, with one and six years of evolution 
that partially improved after the application of 
topical corticosteroids. The plantar lesions had been 
previously biopsied with suggestive signs of eczema.
On physical examination, we observe the following 
mucocutaneous alterations: cheilitis, oral ulcers on the 
tongue and buccal mucosa, erythematous macules 
on the soft palate, erythematous to violaceous 
papules and plaques symmetrically scattered over 
the infraorbital region, chest, back, and lateral 
surface of both arms, and multiple erythematous-
to-violaceous, purpuric, hyperkeratotic papules and 
plaques on palms and heels (Figures 1, 2). There 
Abstract
Chronic granulomatous disease (CGD) is a primary 
immunodeficiency disorder that affects the phagocytic 
cells of the innate immune system. It is characterized 
by recurrent or persistent infections with granuloma 
formation. Lupus-like lesions have been reported in 
carriers of CGD and less frequently, in patients with 
CGD. Immunological study in these patients are 
usually negative. We describe the case of an 8-year-
old boy with CGD who developed chronic and acute 
cutaneous lupus erythematous with angular cheilitis, 
oral ulcers, Raynaud phenomenon, and positive 
serologies for antinuclear, anticentromere, and anti-
Saccharomyces cerevisiae antibodies.
Figure 1. Acute cutaneous lupus erythematous: erythematous to 
violaceous papules and plaques scattered over infraorbital region 
(A), back (B), and external surface of the arms (C).
Figure 2. Chronic cutaneous lupus erythematous: 
Erythematous to violaceous, hyperkeratotic papules and 
plaques on the heels.
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were no other significant symptoms or signs.
The analytical study demonstrated elevated 
sedimentation rate (24mm), antinuclear (1/640), 
anti-centromere (23 U/ml), and anti-Saccharomyces 
cerevisiae (IgA 42.5 U/ml; IgG 81.2 U/ml) antibodies. 
Capillaroscopy was suggestive of Raynaud 
phenomenon. Pulmonary function tests, chest 
radiography, and computed tomography showed no 
significant alterations.
A skin biopsy was performed on the left arm. 
Histopathological, immunohistochemical, and direct 
immunofluorescence examination were suggestive 
of lupus erythematosus (Figure 3).
Accordingly, we assumed the diagnosis of 
cutaneous lupus erythematous (CLE) with chronic 
and acute presentations. The patient started oral 
hydroxychloroquine 6mg/kg/day with resolution of 
all the lesions after 1 month of treatment. Of note, 
his sister, a CGD-carrier, was recently diagnosed with 
CLE, suggesting a shared genetic susceptibility.
Case Discussion
CGD is an autosomal recessive or X-linked primary 
immunodeficiency disorder, characterized by 
defective functioning of nicotinamide adenine 
dinucleotide phosphate (NADPH) enzyme 
responsible for generating reactive oxygen species 
after pathogen phagocytosis [1]. Recurrent or 
persistent infections are commonly observed in 
patients with CGD. Impaired phagocytosis results 
in delayed clearance of certain bacteria, fungi, and 
damaged cells [2]. It has been hypothesized that 
repeated antigen stimulation by non-phagocytosed 
bodies can, theoretically, lead to chronic inflammation 
and promote the overproduction of autoantibodies. 
This could predispose the patient to a broad variety 
of autoimmune diseases, like inflammatory bowel 
disease or lupus erythematous [3-8]. Consequently, 
in genetically predisposed individuals, chronic 
exposure to pathogens may represent the primary 
trigger for the development of autoimmunity. It was 
recently shown that activated CD4+ lymphocytes in 
murine CGD models have a strong tendency towards 
the Th1 pattern of cytokine production, leading to 
excessive inflammation and dominant production 
of IL-17 [2]. Iatrogenic factors, which could impact 
autoimmunity in CGD patients include trimethoprim-
sulfamethoxazole, itraconazole, voriconazole, or 
IFN-γ, but current data lack the statistical power to 
address the potential contribution of any particular 
drug on the development of autoimmune diseases 
[3,6]. Despite the immunocompromised state of CGD, 
prednisone and other immunosuppressive drugs are 
often needed in systemic lupus erythematosus. For 
the cutaneous presentation, hydroxychloroquine is a 
good option for treatment [9]. Owing to the significant 
association of pediatric CLE with systemic lupus 
erythematous, close follow-up is recommended [10]. 
The presented clinical case highlights the fact that, 
although infrequent, autoimmune diseases should 
Figure 3. Histopathological examination: ortokeratotic 
hyperkeratosis, and multifocal areas of interface dermatitis with 
slight perivascular infiltrates of mononuclear cells in the papillary 
and reticular dermis, H&E (200x).
Figure 4. Histopathological examination: deposition of mucin 
between collagen fibers in the dermis, alcian blue stain (400x).
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be considered in the differential diagnosis of new 
cutaneous lesions in CGD patients.
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